Novel manganese-based MOF offers safer alternative to gadolinium MRI contrast
Researchers at Oregon State University have developed a novel manganese-based contrast agent for magnetic resonance imaging that demonstrates superior performance to current gadolinium-based agents whilst offering improved biocompatibility and reduced environmental concerns. The material, designated BVR-19, represents the first application of metal-organic framework technology incorporating the amino acid L-cystine for medical imaging applications.
